Designing the Future
Authors:
- 19 June 2026
- book chapter
- Published by IGI Global Scientific Publishing
- p. 2017-2038
Abstract
Artificial Intelligence (AI) is transforming drug delivery and discovery, promising faster timelines, enhanced efficacy, and personalized treatments. AI has achieved significant advancements in cancer detection, cardiovascular theranostics, and bioinformatics. Machine learning algorithms expedite drug candidate identification by predicting efficacy and safety, streamlining drug development, and enabling precision therapies. AI-driven models also design nanoscale delivery systems for targeted drug release, minimizing side effects and maximizing efficacy. In personalized medicine, AI analyzes genomics, proteomics, and clinical data to identify biomarkers, predict treatment responses, and optimize therapeutic regimens, shifting from one-size-fits-all to tailored interventions based on individual genetic profiles.Keywords
This publication has 58 references indexed in Scilit:
- Anticancer effect of spirooxindole derivatives2024
- Design, synthesis and biological evaluation of novel cationic liposomes loaded with melphalan for the treatment of cancerBioorganic & Medicinal Chemistry Letters, 2023
- Appraisal of fluoroquinolone-loaded carubinose-linked hybrid nanoparticles for glycotargeting to alveolar macrophagesDrug Delivery and Translational Research, 2021
- Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systemsDrug Delivery and Translational Research, 2021
- The significance of artificial intelligence in drug delivery system designAdvanced Drug Delivery Reviews, 2019
- Computational modeling for formulation designDrug Discovery Today, 2019
- Characterization of woodchuck apolipoprotein A‐I: A new tool for drug delivery and identification of altered isoforms in the woodchuck chronic hepatitis modelJournal of Medical Virology, 2011
- Nonlinear transient computation as a potential “kernel trick” in cortical processingBioSystems, 2008
- Toward intelligent decision support for pharmaceutical product developmentJournal of Pharmaceutical Innovation, 2006
- Intravenous Hydrophobic Drug Delivery: A Porous Particle Formulation of Paclitaxel (AI-850)Pharmaceutical Research, 2005